Max Healthcare Institute Limited announced that a hearing concerning petitions filed against its subsidiary, Kalinga Hospital Ltd. (KHL), has been adjourned. The matter was heard by the National Company Law Tribunal, Cuttack Bench, on August 19, 2026. The legal representatives of BRS Capital Two Pte. Limited sought an adjournment, and the tribunal has now scheduled the next hearing for September 8, 2026. This disclosure provides an update on ongoing legal proceedings affecting a key subsidiary.
Legal Proceedings Update for Kalinga Hospital Ltd.
Max Healthcare Institute Limited has provided an update on the ongoing legal proceedings involving its subsidiary, Kalinga Hospital Ltd. (KHL). This disclosure follows a previous intimation dated August 7, 2026, regarding petitions filed before the Hon’ble National Company Law Tribunal, Cuttack Bench. These petitions were lodged by the legal representatives of BRS Capital Two Pte. Limited against KHL, a subsidiary in which Max Healthcare holds a majority equity stake, alongside another shareholder and the Company itself.
Hearing Details and Adjournment
The matter was listed for hearing on August 19, 2026, at 11:30 am (IST). During the proceedings, the legal representatives for BRS Capital Two Pte. Limited requested an adjournment. Consequently, the Hon’ble National Company Law Tribunal (NCLT) has adjourned the hearing and rescheduled it for September 8, 2026. Further details regarding the status and developments of these proceedings will be provided as they emerge.
Disclosure Compliance
This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information presented adheres to the requirements outlined for significant events and developments impacting the company and its subsidiaries. The disclosure will also be hosted on the company’s official website for public access.
Source: BSE
